MediWound (MDWD) Total Current Liabilities (2013 - 2026)
MediWound (MDWD) posted quarterly Total Current Liabilities of $25.7 million for Q4 2025, down 3.14% year-over-year from $26.5 million in Q4 2024, and down 2.08% quarter-over-quarter from $26.3 million in Q3 2025.
MediWound (MDWD) Total Current Liabilities (2013 - 2026) Analysis & Trends
MediWound's Total Current Liabilities history runs 12 years deep, the most recent figure standing at $25.7 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 3.14% year-over-year to $25.7 million; the TTM figure through Dec 2025 stood at $25.7 million (down 3.14% YoY), while the FY2025 annual figure was $25.7 million, down 3.14% from the prior year.
- Total Current Liabilities for Q4 2025 stood at $25.7 million, down from $26.3 million in the prior quarter.
- The five-year high for Total Current Liabilities was $29.1 million in Q2 2025, with the low at $9.0 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $18.1 million (2023), against an average of $18.0 million.
- The sharpest annual moves came in 2021 and 2023: Total Current Liabilities dropped 14.35% in 2021, then jumped 112.78% in 2023.
- MediWound's Total Current Liabilities stood at $10.7 million in 2021, then increased by 12.46% to $12.1 million in 2022, then surged by 50.33% to $18.1 million in 2023, then jumped by 46.43% to $26.5 million in 2024, then slipped by 3.14% to $25.7 million in 2025.
- Business Quant data shows MDWD's Total Current Liabilities at $25.7 million in Q4 2025, $26.3 million in Q3 2025, and $29.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | 18.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.54 Mn |
| Dec 31, 2025 | 25.71 Mn |
| Sep 30, 2025 | 26.25 Mn |
| Jun 30, 2025 | 29.07 Mn |
| Mar 31, 2025 | 21.84 Mn |
| Dec 31, 2024 | 26.54 Mn |
| Sep 30, 2024 | 25.58 Mn |
| Jun 30, 2024 | 22.61 Mn |
| Mar 31, 2024 | 22.34 Mn |
| Dec 31, 2023 | 18.13 Mn |
| Sep 30, 2023 | 17.34 Mn |
| Jun 30, 2023 | 17.99 Mn |
| Mar 31, 2023 | 23.94 Mn |
| Dec 31, 2022 | 12.06 Mn |
| Sep 30, 2022 | 9.01 Mn |
| Jun 30, 2022 | 10.42 Mn |
| Mar 31, 2022 | 11.25 Mn |
| Dec 31, 2021 | 10.72 Mn |
| Sep 30, 2021 | 9.96 Mn |
| Jun 30, 2021 | 9.66 Mn |